Previous studies have suggested that matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) play important roles in the invasion and metastasis of breast cancer (2–4). This evidence concerns the gene MMP9 and breast carcinoma.